IGFBP-3 has shown antitumor activities by regulating proliferation, migration, adhesion, and/or angiogenesis [20,21,22,23,24], and dysregulation of IGFBP-3 has been associated with various human cancers [19]. The gene discussed is IGFBP3; the disease is cancer.